Detection of interferon alpha protein reveals differential levels and cellular sources in disease MP Rodero, J Decalf, V Bondet, D Hunt, GI Rice, S Werneke, ... Journal of experimental medicine 214 (5), 1547-1555, 2017 | 363 | 2017 |
Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature D Kavanagh, S McGlasson, A Jury, J Williams, N Scolding, C Bellamy, ... Blood, The Journal of the American Society of Hematology 128 (24), 2824-2833, 2016 | 122 | 2016 |
TRAIP promotes DNA damage response during genome replication and is mutated in primordial dwarfism ME Harley, O Murina, A Leitch, MR Higgs, LS Bicknell, G Yigit, ... Nature genetics 48 (1), 36-43, 2016 | 97 | 2016 |
Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case–control studies SJ Martin, S McGlasson, D Hunt, J Overell Journal of Neurology, Neurosurgery & Psychiatry 90 (9), 1059-1067, 2019 | 83 | 2019 |
Type I interferon dysregulation and neurological disease S McGlasson, A Jury, A Jackson, D Hunt Nature Reviews Neurology 11 (9), 515-523, 2015 | 60 | 2015 |
Neurological disease in lupus: toward a personalized medicine approach S McGlasson, S Wiseman, J Wardlaw, N Dhaun, DPJ Hunt Frontiers in immunology 9, 1146, 2018 | 57 | 2018 |
Human β‐defensin 3 increases the TLR9‐dependent response to bacterial DNA SL McGlasson, F Semple, H MacPherson, M Gray, DJ Davidson, JR Dorin European journal of immunology 47 (4), 658-664, 2017 | 36 | 2017 |
Human β-D-3 exacerbates MDA5 but suppresses TLR3 responses to the viral molecular pattern mimic polyinosinic: polycytidylic acid F Semple, H MacPherson, S Webb, F Kilanowski, L Lettice, SL McGlasson, ... PLoS genetics 11 (12), e1005673, 2015 | 29 | 2015 |
Neuromyelitis optica in patients with increased interferon alpha concentrations J Williams, S McGlasson, S Irani, D Duffy, Y Crow, D Hunt, ... Lancet Neurology 19 (1), 2019 | 12 | 2019 |
Rare variants of the 3’-5’DNA exonuclease TREX1 in early onset small vessel stroke S McGlasson, K Rannikmäe, S Bevan, C Logan, LS Bicknell, A Jury, ... Wellcome Open Research 2, 2017 | 9 | 2017 |
Synapses pruned in lupus S McGlasson, D Hunt Nature 546 (7659), 482-483, 2017 | 7 | 2017 |
The brain microvasculature is a primary mediator of interferon-α neurotoxicity in human cerebral interferonopathies B Viengkhou, E Hayashida, S McGlasson, K Emelianova, D Forbes, ... Immunity, 2024 | 5 | 2024 |
TREX1: The varying and overlapping manifestations of disease T Briggs, D McKee, S McGlasson, P D'Urso, T Hardy, A Herwadkar, ... EUROPEAN JOURNAL OF HUMAN GENETICS 32, 171-171, 2024 | | 2024 |
Phenotypes associated with genetic determinants of type I interferon regulation in the UK Biobank: a protocol B Rioux, M Chong, R Walker, S McGlasson, K Rannikmäe, D McCartney, ... Wellcome Open Research 8, 2023 | | 2023 |
CSF neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case control studies SJ Martin, S McGlasson, D Hunt, J Overell MULTIPLE SCLEROSIS JOURNAL 24, 658-658, 2018 | | 2018 |
small vessel stroke [version 1; referees: 2 approved] S McGlasson, K Rannikmäe, S Bevan, C Logan, AP Jackson, HS Markus, ... | | 2017 |
ELEVATED INTERFERON-ALPHA CAUSES CEREBRAL MICROVASCULAR DISEASE: A MODEL FOR NEUROLUPUS? D Hunt, I Campbell, S McGlasson, A Jury, A Jackson CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 34 (4), S27-S27, 2016 | | 2016 |
Correction: Human β-D-3 Exacerbates MDA5 but Suppresses TLR3 Responses to the Viral Molecular Pattern Mimic Polyinosinic: Polycytidylic Acid F Semple, H MacPherson, S Webb, F Kilanowski, L Lettice, SL McGlasson, ... Plos Genetics 12 (1), e1005801, 2016 | | 2016 |
Regulation of the innate immune system SL McGlasson The University of Edinburgh, 2015 | | 2015 |
The brain microvasculature is a primary mediator of interferon-a neurotoxicity in human cerebral interferonopathies B Viengkhou, E Hayashida, S McGlasson, IL Campbell, DPJ Hunt, ... | | |